Analyst Ratings for Maravai LifeScience Holdings Inc. (MRVI) [Neutrals]
MRVI Rating Summary
MRVI Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $6.00 (UBS)
- Average: $11.09
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$11.09 (+43.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$11.09 (+43.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2023 | KeyBanc | Paul Knight | Downgrade | Sector Weight (Overweight) |
N/A (N/A) |
11.50 (7.72) |
-32.87% | Details |
| 5/23/2023 | Credit Suisse » Updated 8/8/2023 |
Dan Leonard | Downgrade | Neutral (Outperform) |
11.00 (14.00) |
13.38 (7.72) |
-42.3% | Details |
 |
||||||||
|
||||||||
